sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - fenilketonurije - drugi zdravljene bolezni prebavil in presnove izdelki, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastična sredstva - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
ceplene
laboratoires delbert - histamin dihydrochloride - leukemija, myeloid, akutna - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). učinkovitost zdravila ceplene ni bila v celoti dokazana pri bolnikih, starejših od 60 let.
cufence
univar solutions bv - trientine dihydrochloride - hepatolentikularna degeneracija - drugi zdravljene bolezni prebavil in presnove izdelki, - cufence je primerna za zdravljenje wilsonova bolezen pri bolnikih nestrpni do d-penicillamine terapija, pri odraslih in otrok, starih 5 let ali starejši.
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioedem, dedno - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinom, pljučni pljuč - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
trientine dihydrochloride 300 mg kapsule
lenis d.o.o. - trientinijev diklorid - kapsula, trda - trientinijev diklorid 300 mg / 1 kapsula - trientin
kuvan
biomarin international limited - sapropterin dihydrochloride - fenilketonurije - drugi zdravljene bolezni prebavil in presnove izdelki, - kuvan je indiciran za zdravljenje hiperfenilalaninemije (hpa) pri odraslih in pediatričnih bolnikih vseh starosti s fenilketonurijo (pku), za katere se je izkazalo, da so odzivne na takšno zdravljenje. kuvan je tudi primerna za zdravljenje hyperphenylalaninaemia (hpa) pri odraslih in pediatričnih bolnikih vseh starosti z tetrahydrobiopterin (bh4) pomanjkljivosti, ki so pokazale, da se je treba odzivati na tako zdravljenje.
trientine dihydrochloride 300 mg kapsule
sanolabor, d.d. - kapsula, trda - antidoti
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, myeloid, akutna - antineoplastična sredstva - zdravljenje akutno mieloično levkemijo.